McPherron Aviva sold OFIX
June 18, 2026 · Form 4 insider transaction
McPherron Aviva sold 3,670 shares of Orthofix Medical Inc. at $9.38 per share, a transaction worth $34.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.; Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).